Farnesylation or geranylgeranylation? Efficient assays for testing protein prenylation in vitro and in vivo.
Farnesylation or geranylgeranylation? Efficient assays for testing protein prenylation in vitro and in vivo.
复制标题
法尼化或黄烷基凝聚力?在体外和体内测试蛋白质原始化的有效测定。
DOI:
10.1186/1471-2091-7-6
复制
发表时间:
2006-02-28
期刊:
影响因子:
--
通讯作者:
Eisenhaber, Frank
中科院分区:
文献类型:
--
作者:
Benetka, Wolfgang;Koranda, Manfred;Maurer-Stroh, Sebastian;Pittner, Fritz;Eisenhaber, Frank
Available in vitro and in vivo methods for verifying protein substrates for posttranslational modifications via farnesylation or geranylgeranylation (for example, autoradiography with 3H-labeled anchor precursors) are time consuming (weeks/months), laborious and suffer from low sensitivity. We describe a new technique for detecting prenyl anchors in N-terminally glutathione S-transferase (GST)-labeled constructs of target proteins expressed in vitro in rabbit reticulocyte lysate and incubated with 3H-labeled anchor precursors. Alternatively, hemagglutinin (HA)-labeled constructs expressed in vivo (in cell culture) can be used. For registration of the radioactive marker, we propose to use a thin layer chromatography (TLC) analyzer. As a control, the protein yield is tested by Western blotting with anti-GST- (or anti-HA-) antibodies on the same membrane that has been previously used for TLC-scanning. These protocols have been tested with Rap2A, v-Ki-Ras2 and RhoA (variant RhoA63L) including the necessary controls. We show directly that RasD2 is a farnesylation target. Savings in time for experimentation and the higher sensitivity for detecting 3H-labeled lipid anchors recommend the TLC-scanning method with purified GST- (or HA-) tagged target proteins as the method of choice for analyzing their prenylation capabilities in vitro and in vivo and, possibly, also for studying the myristoyl and palmitoyl posttranslational modifications.